Drug Shortage Report for PMS-VENLAFAXINE XR

Last updated on 2022-07-25 History
Report ID 6868
Drug Identification Number 02278553
Brand name PMS-VENLAFAXINE XR
Common or Proper name VENLAFAXINE
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 75MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-07-30
Estimated end date
Actual end date 2022-06-27
Shortage status Resolved
Updated date 2022-07-25
Company comments See Discontinuation report 165500
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2022-07-25 French Compare
v15 2022-07-25 English Compare
v14 2021-10-15 French Compare
v13 2021-10-15 English Compare
v12 2021-06-18 French Compare
v11 2021-06-18 English Compare
v10 2020-07-07 French Compare
v9 2020-07-07 English Compare
v8 2019-12-24 French Compare
v7 2019-12-24 English Compare
v6 2019-11-15 French Compare
v5 2019-11-15 English Compare
v4 2019-07-31 French Compare
v3 2019-07-31 English Compare
v2 2017-04-13 French Compare
v1 2017-04-13 English Compare

Showing 1 to 16 of 16